Principal Investigator: Shivang Dave, CEO
Research: Objective refraction with self-operable, lightweight autorefractor
Start date: April 1, 2019
End date: March 31, 2020
Study type: Ground study
Project: Over a billion people worldwide suffer from poor vision because they do not have adequate access to eye care professionals who can prescribe affordable eyeglasses. To meet this need, PlenOptika developed QuickSee, a portable, durable, low cost, yet highly accurate binocular autorefractor to quickly measure refractive errors and to monitor changes over time, making effective prescriptions easier to obtain. PlenOptika is planning a lighter model to make QuickSee easier to use for children and elderly patients, and other design advancements for faster and more reliable measurements.
PlenOptika designs innovative technologies to improve vision care globally. Their flagship device the QuickSee™ Wavefront Refractor was born at MIT, incubated at Harvard and Boston University, and raised around the world to meet high standards of vision and health care professionals under both rigorous clinical and demanding global health conditions. QuickSee’s accuracy has been published in peer-reviewed journals, it has earned international recognition and awards, and it is currently in use by private and nonprofit healthcare organizations internationally. www.plenoptika.com
Commercial potential on Earth: By miniaturizing and making QuickSee easier to use, PlenOptika will extend optometry/ophthalmology testing further in low resource environments across the world. Early detection of refractive errors and vision changes in vulnerable populations provides economic benefit not only to patients but also to payers, including state and federal Medicaid agencies.